Respiratory Medicine
Volume 104, Issue 8 , Pages 1110-1120 , August 2010

Down-titration from high-dose combination therapy in asthma: Removal of long-acting β2-agonist

  • Helen K. Reddel

      Affiliations

    • Woolcock Institute of Medical Research, PO Box M77, Missenden Rd PO, Camperdown NSW 2050, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9114 0437; fax: +61 2 9114 0014.
    • ,
  • Peter G. Gibson

      Affiliations

    • Hunter Medical Research Institute, John Hunter Hospital, Lookout Road, New Lambton NSW 2305, Australia
    • ,
  • Matthew J. Peters

      Affiliations

    • Concord Repatriation General Hospital, Hospital Rd, Concord NSW 2139, Australia
    • ,
  • Peter A.B. Wark

      Affiliations

    • Hunter Medical Research Institute, John Hunter Hospital, Lookout Road, New Lambton NSW 2305, Australia
    • ,
  • Ingrid B. Sand

      Affiliations

    • GlaxoSmithKline Australia, 1061 Mountain Hwy, Boronia, Victoria 3155, Australia
    • ,
  • Camilla M. Hoyos

      Affiliations

    • Woolcock Institute of Medical Research, PO Box M77, Missenden Rd PO, Camperdown NSW 2050, Australia
    • ,
  • Christine R. Jenkins

      Affiliations

    • Woolcock Institute of Medical Research, PO Box M77, Missenden Rd PO, Camperdown NSW 2050, Australia

Received 9 October 2009 ,Accepted 5 April 2010.

References 

  1. Greenstone IIG, Ni Chroinin M, Lasserson TJ, Ducharme F. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database of Systematic Reviews. 2009;
  2. Global Initiative for Asthma . Global strategy for asthma management and prevention. www.ginasthma.comMarch 2009;
  3. National Asthma Education and Prevention Program . Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of Asthma-summary report 2007. J Allergy Clin Immunol. 2007;120:S94–S138
  4. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994;331:700–705
  5. Lofdahl CG, Reiss TF, Leff JA, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319:87–90
  6. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001;163:406–412
  7. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC. Stepping down inhaled corticosteroids in asthma: randomised controlled trial. BMJ. 2003;326:1115
  8. Gershman NH, Wong HH, Liu JT, Fahy JV. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J. 2000;15:11–18
  9. Gibson PG, Powell H, Ducharme FM. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Cochrane Database Syst Rev. 2009;
  10. McIvor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med. 1998;158:924–930
  11. Food and Drug Administration . FDA drug safety communication: new safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). [18/2/2010]; Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm2010;
  12. Bateman ED, Jacques L, Goldfrad C, Atienza T, Mihaescu T, Duggan M. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol. 2006;117:563–570
  13. Godard P, Greillier P, Pigearias B, Nachbaur G, Desfougeres JL, Attali V. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study. Respir Med. 2008;102:1124–1131
  14. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med. 1995;152:800–803
  15. Salome CM, Roberts AM, Brown NJ, Dermand J, Marks GB, Woolcock AJ. Exhaled nitric oxide measurements in a population sample of young adults. Am J Respir Crit Care Med. 1999;159:911–916
  16. American Thoracic Society . Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. 1993;16:5–40
  18. Yan K, Salome CM, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax. 1983;38:760–765
  19. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE. Standardised methodology of sputum induction and processing. Eur Respir J. 2002;20:1s–52s
  20. Gibson PG, Woolley KL, Carty K, Murree-Allen K, Saltos N. Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD). Clin Exp Allergy. 1998;28:1081–1088
  21. Holz O, Mucke M, Zarza P, Loppow D, Jorres RA, Magnussen H. Freezing of homogenized sputum samples for intermittent storage. Clin Exp Allergy. 2001;31:1328–1331
  22. Graham JA, Pavlicek PK, Sercombe JK, Xavier ML, Tovey ER. The nasal air sampler: a device for sampling inhaled aeroallergens. Ann Allergy Asthma Immunol. 2000;84:599–604
  23. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907
  24. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol. 1992;45:461–472
  25. Reddel HK, Jenkins CR, Marks GB, et al. Optimal asthma control, starting with high doses of inhaled budesonide. [erratum in Eur Respir J 2000;16:579] Eur Respir J. 2000;16:226–235
  26. Marks GB, Dunn SM, Woolcock AJ. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J Clin Epidemiol. 1993;46:1103–1111
  27. Juniper EF, Bousquet J, Abetz L, Bateman ED. The goal committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100:616–621
  28. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54–61
  29. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170:836–844
  30. Australian Centre for Asthma Monitoring . Asthma in Australia. Canberra: Australian Institute of Health and Welfare; 2003;
  31. Woolcock A, Rubinfeld AR, Seale JP, et al. Thoracic Society of Australia and New Zealand. Asthma management plan. Med J Aust. 1989;151:650–653
  32. National Heart Lung and Blood Institute . International consensus report on diagnosis and treatment of asthma. Eur Respir J. 1992;5:601–641
  33. Diette GB, Patino CM, Merriman B, et al. Patient factors that physicians use to assign asthma treatment. Arch Intern Med. 2007;167:1360–1366
  34. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust. 2003;178:223–225
  35. Gibson PG, Powell H, Ducharme FM. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol. 2007;119:344–350
  36. Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363:271–275
  37. FitzGerald JM, Becker A, Sears MR, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax. 2004;59:550–556
  38. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99
  39. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest. 1995;108:10–15
  40. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med. 1975;292:1152–1155
  41. Belda J, Parameswaran K, Lemiere C, Kamada D, O’Byrne PM, Hargreave FE. Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J. 2006;13:129–133
  42. Prince P, Bertrand M, Boulay ME, Bernier MC, Boulet LP. Optimization of the conditions for preservation of induced sputum: influence of freezing on cellular analysis. Chest. 2005;128:980–985
  43. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL study group. Am J Respir Crit Care Med. 1999;159:1043–1051
  44. Rasmussen F, Taylor DR, Flannery EM, et al. Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol. 2002;110:220–227
  45. Marabini A, Cardinalini G, Severini C, Ripandelli A, Siracusa A. Is normal bronchial responsiveness in asthmatics a reliable index for withdrawing inhaled corticosteroid treatment?. Chest. 1998;113:964–967
  46. Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax. 1981;36:575–579
  47. Foster JM, van Sonderen E, Lee AJ, et al. A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir Res. 2006;7:131

PII: S0954-6111(10)00156-3

doi: 10.1016/j.rmed.2010.04.003

Respiratory Medicine
Volume 104, Issue 8 , Pages 1110-1120 , August 2010

Article Tools

* Image Usage & Resolution